Sepio Capital’s Edwards Lifesciences EW Stock Holding History

Sepio Capital’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-3,983	Closed	-$275K	–	335
2020 Q2	$275K	Buy	+3,983	New	+$283K	0.03%	258

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sepio Capital's EW Position: Q3 2020 in Review

Sepio Capital sold out of Edwards Lifesciences (EW) in Q3 2020, closing a stake of 3,983 shares — an estimated $275K sold.

Sepio Capital first reported a position in EW in Q2 2020 and held it in 1 quarter. The position peaked at $275K in Q2 2020. 1,083 funds tracked by Wall St. Rank hold EW as of Q3 2020.

Sepio Capital reported no remaining Edwards Lifesciences position as of Q3 2020 after selling out during the quarter.
Sepio Capital sold 3,983 Edwards Lifesciences shares in Q3 2020, an estimated $275K.
Sepio Capital first reported a position in Edwards Lifesciences in Q2 2020 and held it in 1 quarter.
Sepio Capital's Edwards Lifesciences position peaked at $275K in Q2 2020.
1,083 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q3 2020.

Based on Sepio Capital's 13F filing for Q3 2020, filed 12 Nov 2020.